Variant report

Variant	nsv878995
Chromosome Location	chr4:46422329-46589847
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:46427895-46428150	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:46447777-46448326	HepG2	liver:	n/a	n/a
3	BACH1	chr4:46461431-46461611	H1-hESC	embryonic stem cell:	n/a	n/a
4	BATF	chr4:46552555-46552755	GM12878	blood:	n/a	n/a
5	BHLHE40	chr4:46427837-46428124	HepG2	liver:	n/a	n/a
6	BHLHE40	chr4:46447814-46448154	HepG2	liver:	n/a	n/a
7	CEBPB	chr4:46443060-46443685	Hela-S3	cervix:	n/a	chr4:46443141-46443152
8	CEBPB	chr4:46427799-46428190	IMR90	lung:	n/a	chr4:46428064-46428077 chr4:46427959-46427970
9	CEBPB	chr4:46505762-46506133	HepG2	liver:	n/a	chr4:46505939-46505950
10	CEBPB	chr4:46434975-46435288	Hela-S3	cervix:	n/a	n/a
11	CEBPB	chr4:46447820-46448356	IMR90	lung:	n/a	chr4:46447870-46447881
12	CEBPB	chr4:46505767-46506123	H1-hESC	embryonic stem cell:	n/a	chr4:46505939-46505950
13	CEBPB	chr4:46538744-46539025	HepG2	liver:	n/a	chr4:46538881-46538892
14	CEBPB	chr4:46563532-46563834	HepG2	liver:	n/a	n/a
15	CEBPB	chr4:46427915-46428096	H1-hESC	embryonic stem cell:	n/a	chr4:46428064-46428077 chr4:46427959-46427970
16	CEBPB	chr4:46510167-46510534	A549	lung:	n/a	chr4:46510421-46510432
17	CEBPB	chr4:46510286-46510589	Hela-S3	cervix:	n/a	chr4:46510421-46510432
18	CEBPB	chr4:46427790-46428173	HepG2	liver:	n/a	chr4:46428064-46428077 chr4:46427959-46427970
19	CEBPB	chr4:46513546-46513795	IMR90	lung:	n/a	chr4:46513637-46513648
20	CEBPB	chr4:46505785-46506053	ECC-1	luminal epithelium:	n/a	chr4:46505939-46505950
21	CEBPB	chr4:46505772-46506131	A549	lung:	n/a	chr4:46505939-46505950
22	CEBPB	chr4:46510260-46510588	HepG2	liver:	n/a	chr4:46510421-46510432
23	CEBPB	chr4:46510276-46510594	IMR90	lung:	n/a	chr4:46510421-46510432
24	CEBPB	chr4:46513495-46513778	HepG2	liver:	n/a	chr4:46513637-46513648
25	CEBPB	chr4:46427852-46428046	HepG2	liver:	n/a	chr4:46427959-46427970
26	CEBPB	chr4:46505774-46506118	Hela-S3	cervix:	n/a	chr4:46505939-46505950
27	CEBPB	chr4:46490053-46490131	HepG2	liver:	n/a	n/a
28	CEBPB	chr4:46509558-46509803	HepG2	liver:	n/a	chr4:46509695-46509704 chr4:46509693-46509704 chr4:46509695-46509704 chr4:46509695-46509706 chr4:46509695-46509704 chr4:46509695-46509704 chr4:46509693-46509706
29	CEBPB	chr4:46513629-46513664	K562	blood:	n/a	chr4:46513637-46513648
30	CEBPB	chr4:46447719-46448353	HepG2	liver:	n/a	chr4:46447870-46447881
31	CEBPB	chr4:46563515-46563858	IMR90	lung:	n/a	n/a
32	CEBPB	chr4:46434336-46434463	IMR90	lung:	n/a	n/a
33	CEBPB	chr4:46427776-46428229	Hela-S3	cervix:	n/a	chr4:46428064-46428077 chr4:46427959-46427970
34	CEBPB	chr4:46434949-46435302	IMR90	lung:	n/a	n/a
35	CEBPB	chr4:46510328-46510516	H1-hESC	embryonic stem cell:	n/a	chr4:46510421-46510432
36	CEBPB	chr4:46447698-46448373	Hela-S3	cervix:	n/a	chr4:46447870-46447881
37	CEBPB	chr4:46513553-46513776	A549	lung:	n/a	chr4:46513637-46513648
38	CEBPB	chr4:46505762-46506131	K562	blood:	n/a	chr4:46505939-46505950
39	CEBPB	chr4:46505757-46506138	IMR90	lung:	n/a	chr4:46505939-46505950
40	CTCF	chr4:46526330-46526401	Lung_OC	lung:	n/a	n/a
41	CTCF	chr4:46562940-46563090	HCM	heart:	n/a	chr4:46562989-46562997
42	CTCF	chr4:46562940-46563090	HCPEpiC	choroid plexus:	n/a	chr4:46562989-46562997
43	CTCF	chr4:46562920-46563070	HPAF	blood vessel:	n/a	chr4:46562989-46562997
44	CTCF	chr4:46492560-46492710	HepG2	liver:	n/a	n/a
45	CTCF	chr4:46562900-46563050	HMEC	breast:	n/a	chr4:46562989-46562997
46	CTCF	chr4:46492625-46492710	MCF-7	breast:	n/a	n/a
47	CTCF	chr4:46480740-46480890	GM12864	blood:	n/a	n/a
48	CTCF	chr4:46562940-46563090	HMEC	breast:	n/a	chr4:46562989-46562997
49	CTCF	chr4:46431340-46431490	HMF	breast:	n/a	n/a
50	E2F4	chr4:46468653-46468704	MCF10A-Er-Src	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:46478987-46479037	SAEC	small airway:	n/a
2	chr4:46478987-46479037	NHBE	bronchial:	n/a
3	chr4:46478987-46479037	HRE	kidney:	n/a
4	chr4:46427528-46427578	Caco-2	colon:	n/a
5	chr4:46478987-46479037	HCPEpiC	choroid plexus:	n/a
6	chr4:46427528-46427578	BE2_C	brain:	n/a
7	chr4:46478987-46479037	AG04450	lung:	fetal
8	chr4:46478987-46479037	Hela-S3	cervix:	n/a
9	chr4:46427528-46427578	NB4	blood:	n/a
10	chr4:46427528-46427578	SK-N-SH_RA	brain:	n/a
11	chr4:46478987-46479037	GM12878	blood:	n/a
12	chr4:46427528-46427578	ovcar-3	ovarian:	n/a
13	chr4:46427528-46427578	LNCaP	prostate:	n/a
14	chr4:46478987-46479037	ProgFib	skin:	n/a
15	chr4:46427528-46427578	HNPCEpiC	eye:	n/a
16	chr4:46427528-46427578	AG10803	skin:	n/a
17	chr4:46478987-46479037	CMK	blood:	n/a
18	chr4:46478987-46479037	Hepatocyte	liver:	n/a
19	chr4:46478987-46479037	HCF	heart:	n/a
20	chr4:46427528-46427578	HAEpiC	amniotic membrane:	n/a
21	chr4:46427528-46427578	ECC-1	luminal epithelium:	n/a
22	chr4:46478987-46479037	ECC-1	luminal epithelium:	n/a
23	chr4:46478987-46479037	GM19239	blood:	n/a
24	chr4:46478987-46479037	AoSMC	blood vessel:	n/a
25	chr4:46478987-46479037	HCM	heart:	n/a
26	chr4:46478987-46479037	SK-N-SH	brain:	n/a
27	chr4:46427528-46427578	HRPEpiC	eye:	n/a
28	chr4:46478987-46479037	HUVEC	blood vessel:	n/a
29	chr4:46478987-46479037	HRPEpiC	eye:	n/a
30	chr4:46478987-46479037	H1-hESC	embryonic stem cell:	embryo
31	chr4:46427528-46427578	BJ	skin:	n/a
32	chr4:46478987-46479037	K562	blood:	n/a
33	chr4:46427528-46427578	AG09309	skin:	n/a
34	chr4:46427528-46427578	MCF-7	breast:	n/a
35	chr4:46478987-46479037	AG09309	skin:	n/a
36	chr4:46427528-46427578	GM12891	blood:	n/a
37	chr4:46427528-46427578	NHBE	bronchial:	n/a
38	chr4:46427528-46427578	IMR90	lung:	fetal
39	chr4:46478987-46479037	AG04449	skin:	fetal
40	chr4:46427528-46427578	HCT-116	colon:	n/a
41	chr4:46427528-46427578	PrEC	prostate:	n/a
42	chr4:46478987-46479037	PANC-1	pancreas:	n/a
43	chr4:46427528-46427578	Jurkat	blood:	n/a
44	chr4:46427528-46427578	HPAEpiC	pulmonary alveolar:	n/a
45	chr4:46427528-46427578	SK-N-MC	brain:	n/a
46	chr4:46478987-46479037	HEK293	kidney:	embryo
47	chr4:46427528-46427578	HIPEpiC	eye:	n/a
48	chr4:46478987-46479037	HAEpiC	amniotic membrane:	n/a
49	chr4:46478987-46479037	AG09319	gingival:	n/a
50	chr4:46427528-46427578	SAEC	small airway:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr4:46444130..46446100-chr4:46557651..46559731,2	K562	blood:
2	chr4:46444130..46446100-chr4:46557651..46559731,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GABRB1-2	chr4:46435095-46435205	ENSG00000249330.1

Variant related genes	Relation type
RNU6-412P	TF binding region
GABRA2	TF binding region
RNU6-412P	CpG island
GABRA2	CpG island

Extended variants
information (count: 2100 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:2100 , 50 per page) page: 1 2 3 4 5 6 7 ... 42

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs536219097	chr4:46427455-46427456	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs192569610	chr4:46427481-46427482	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs573233780	chr4:46427483-46427484	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs553373992	chr4:46427498-46427499	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs540767603	chr4:46427503-46427504	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs558874795	chr4:46427540-46427541	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs568203529	chr4:46427583-46427584	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs577470988	chr4:46427598-46427599	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs146646454	chr4:46427621-46427622	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs141339485	chr4:46427652-46427653	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs536087404	chr4:46427748-46427749	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs547959403	chr4:46427755-46427756	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs530429380	chr4:46427763-46427764	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs541442224	chr4:46427776-46427777	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs560142520	chr4:46427777-46427778	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs80031493	chr4:46427786-46427787	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs527388163	chr4:46427800-46427801	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs552211170	chr4:46427804-46427805	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs185626695	chr4:46427809-46427810	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs145093357	chr4:46427842-46427843	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs549581363	chr4:46427868-46427869	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs190530147	chr4:46427889-46427890	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs535769004	chr4:46427890-46427891	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs554663158	chr4:46427922-46427923	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs555456883	chr4:46428003-46428004	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs377144859	chr4:46428024-46428025	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs533949364	chr4:46428045-46428046	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs575067120	chr4:46428047-46428048	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs76127832	chr4:46428080-46428081	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs544397460	chr4:46428089-46428090	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs566687498	chr4:46428211-46428212	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs544778790	chr4:46428260-46428261	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs193062792	chr4:46428329-46428330	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs184672400	chr4:46428357-46428358	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs542551844	chr4:46428359-46428360	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs560633479	chr4:46428372-46428373	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs527240832	chr4:46428424-46428425	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs148354387	chr4:46428459-46428460	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs34401065	chr4:46428464-46428465	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs563805017	chr4:46428465-46428466	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs189041635	chr4:46428523-46428524	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs114656842	chr4:46428532-46428533	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs567960297	chr4:46428552-46428553	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs529164874	chr4:46428601-46428602	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs547628117	chr4:46428616-46428617	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs565837063	chr4:46428667-46428668	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs7665962	chr4:46428806-46428807	Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs113411828	chr4:46428814-46428815	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs570940576	chr4:46428840-46428841	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs538391554	chr4:46428858-46428859	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
Oral squamous cell carcinoma	17134496	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21858162	CNVD
small cell lung cancer	20016488	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Olfactory neuroblastoma	18408657	CNVD
Cancer	22183965	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Multiple myeloma	16616336	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	20164919	CNVD
Renal cell carcinoma	18765545	CNVD
Gastric cancer	16891809	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:115 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:46427400-46428000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
2	chr4:46427400-46428600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr4:46427800-46428400	Enhancers	HUES48 Cell Line	embryonic stem cell
4	chr4:46427800-46428600	Enhancers	HMEC	breast
5	chr4:46428000-46428400	Enhancers	ES-I3 Cell Line	embryonic stem cell
6	chr4:46428000-46428400	Enhancers	Adipose Nuclei	Adipose
7	chr4:46428000-46428600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
8	chr4:46428000-46428600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr4:46428000-46428600	Enhancers	Hela-S3	cervix
10	chr4:46428400-46433600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
11	chr4:46428400-46433800	Weak transcription	HUES48 Cell Line	embryonic stem cell
12	chr4:46428600-46429400	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr4:46428600-46434600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
14	chr4:46429400-46434600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
15	chr4:46433600-46436200	Enhancers	ES-I3 Cell Line	embryonic stem cell
16	chr4:46433800-46436200	Enhancers	HUES48 Cell Line	embryonic stem cell
17	chr4:46434000-46434800	Enhancers	Fetal Lung	lung
18	chr4:46434000-46435600	Enhancers	iPS-20b Cell Line	embryonic stem cell
19	chr4:46434000-46435800	Enhancers	HUES64 Cell Line	embryonic stem cell
20	chr4:46434600-46435600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr4:46434600-46435800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
22	chr4:46434600-46435800	Enhancers	Cortex derived primary cultured neurospheres	brain
23	chr4:46434600-46435800	Enhancers	HMEC	breast
24	chr4:46434600-46435800	Enhancers	NHEK	skin
25	chr4:46434600-46436000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr4:46434600-46436000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
27	chr4:46434800-46435600	Weak transcription	Fetal Lung	lung
28	chr4:46435600-46435800	Enhancers	Fetal Lung	lung
29	chr4:46435600-46436000	Enhancers	iPS-18 Cell Line	embryonic stem cell
30	chr4:46435800-46437000	Weak transcription	NHEK	skin
31	chr4:46436000-46436600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr4:46436600-46436800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
33	chr4:46437000-46437200	Enhancers	NHEK	skin
34	chr4:46442800-46446000	Weak transcription	NHDF-Ad	bronchial
35	chr4:46443000-46444000	Enhancers	Hela-S3	cervix
36	chr4:46443200-46443800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
37	chr4:46443600-46443800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr4:46443800-46445000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
39	chr4:46443800-46445000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
40	chr4:46444000-46447800	Weak transcription	Hela-S3	cervix
41	chr4:46445000-46445400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
42	chr4:46445000-46445800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr4:46445000-46446000	Enhancers	HMEC	breast
44	chr4:46445800-46446200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
45	chr4:46446000-46446400	Weak transcription	HMEC	breast
46	chr4:46446200-46448600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
47	chr4:46446400-46446600	Enhancers	HMEC	breast
48	chr4:46446600-46447800	Weak transcription	HMEC	breast
49	chr4:46447800-46448000	Enhancers	Hela-S3	cervix
50	chr4:46447800-46448200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links